Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer.

Huayi LiZikun PengJianqing ZhuWeidong ZhaoYi HuangRuifang AnHong ZhengPengpeng QuLi WangQi ZhouDanbo WangGe LouJing WangKe WangBeihua KongXing XieRutie YinJohn LowAbdul Malik RozitaLim Chun SenYong Chee MengKho Swee KiongJihong LiuZhiqing LiangWeiguo LvYaping ZhuWeiguo HuWei SunJingya SuQiqi WangRongyu ZangDing MaQing-Lei Gao

Published in: BMC medicine (2024)

NCT03534453. Registered at May 23, 2018.

Keyphrases

phase iii
open label
clinical trial
acute lymphoblastic leukemia
acute myeloid leukemia
double blind
multiple myeloma
placebo controlled
bone marrow
mesenchymal stem cells
study protocol
data analysis